New app aims to help cancer patients report side effects from home

NCT ID NCT04915274

Completed Knowledge-focused Sponsor: Centre Hospitalier Régional Metz-Thionville Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a smartphone app called QuestOnco can reliably track side effects in 134 adult cancer patients receiving active treatment. Patients used the app to report symptoms, and researchers compared those reports to standard paper questionnaires. The goal was to see if the app is a valid and easy way for patients to communicate treatment side effects to their doctors.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: QuestOnco mobile application
What this could lead to: If validated, this app could give doctors a reliable way to monitor cancer treatment side effects remotely, improving patient care.
What could go wrong: This is a small, completed validation study, not a treatment trial. The app may not work for all patients or may have technical issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER

Contacts and locations

Locations

Centre Régional Metz-Thionville

Metz, 57085, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.